Mesalazine reduces mutations in transforming growth factor beta receptor II and activin type II receptor by improvement of replication fidelity in mononucleotide repeats.
about
Mesalazine and thymoquinone attenuate intestinal tumour development in Msh2(loxP/loxP) Villin-Cre miceThe 5-aminosalicylic acid antineoplastic effect in the intestine is mediated by PPARγ.Colorectal cancer chemoprevention by mesalazine and its derivatives.Colorectal cancer in inflammatory bowel disease: results of the 3rd ECCO pathogenesis scientific workshop (I).Mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDs) and mesalazine in the chemoprevention of colorectal cancer.Identification of PMN-released Mutagenic Factors in a Co-culture Model for Colitis-associated Cancer.
P2860
Mesalazine reduces mutations in transforming growth factor beta receptor II and activin type II receptor by improvement of replication fidelity in mononucleotide repeats.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Mesalazine reduces mutations i ...... ity in mononucleotide repeats.
@en
Mesalazine reduces mutations i ...... ity in mononucleotide repeats.
@nl
type
label
Mesalazine reduces mutations i ...... ity in mononucleotide repeats.
@en
Mesalazine reduces mutations i ...... ity in mononucleotide repeats.
@nl
prefLabel
Mesalazine reduces mutations i ...... ity in mononucleotide repeats.
@en
Mesalazine reduces mutations i ...... ity in mononucleotide repeats.
@nl
P2093
P2860
P1476
Mesalazine reduces mutations i ...... lity in mononucleotide repeats
@en
P2093
Christoph Campregher
Clemens Honeder
Heekyung Chung
John M Carethers
P2860
P304
P356
10.1158/1078-0432.CCR-09-2854
P407
P577
2010-03-02T00:00:00Z